|
1
|
Anderson ME: Update on survival in
osteosarcoma. Orthop Clin North Am. 47:283–292. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Duchman KR, Gao Y and Miller BJ:
Prognostic factors for survival in patients with high-grade
osteosarcoma using the Surveillance, Epidemiology, and End Results
(SEER) Program database. Cancer Epidemiol. 39:593–599. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Rosen G: Preoperative (neoadjuvant)
chemotherapy for osteogenic sarcoma: A ten year experience.
Orthopedics. 8:659–664. 1985.PubMed/NCBI
|
|
4
|
Lendahl U, Lee KL, Yang H and Poellinger
L: Generating specificity and diversity in the transcriptional
response to hypoxia. Nat Rev Genet. 10:821–832. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wang GL and Semenza GL: Characterization
of hypoxia-inducible factor 1 and regulation of DNA binding
activity by hypoxia. J Biol Chem. 268:21513–21518. 1993.PubMed/NCBI
|
|
6
|
Parks SK, Chiche J and Pouysségur J:
Disrupting proton dynamics and energy metabolism for cancer
therapy. Nat Rev Cancer. 13:611–623. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Li N, Li Y, Li Z, Huang C, Yang Y, Lang M,
Cao J, Jiang W, Xu Y, Dong J, et al: Hypoxia inducible factor 1
(HIF-1) recruits macrophage to activate pancreatic stellate cells
in pancreatic ductal adenocarcinoma. Int J Mol Sci. 17:172016.
|
|
8
|
Mouriaux F, Sanschagrin F, Diorio C,
Landreville S, Comoz F, Petit E, Bernaudin M, Rousseau AP, Bergeron
D and Morcos M: Increased HIF-1α expression correlates with cell
proliferation and vascular markers CD31 and VEGF-A in uveal
melanoma. Invest Ophthalmol Vis Sci. 55:1277–1283. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Guo M, Cai C, Zhao G, Qiu X, Zhao H, Ma Q,
Tian L, Li X, Hu Y, Liao B, et al: Hypoxia promotes migration and
induces CXCR4 expression via HIF-1α activation in human
osteosarcoma. PLoS One. 9:e905182014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhan H, Liang H, Liu X, Deng J, Wang B and
Hao X: Expression of Rac1, HIF-1α, and VEGF in gastric carcinoma:
Correlation with angiogenesis and prognosis. Onkologie. 36:102–107.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Marton I, Knezevic F, Ramic S, Milosevic M
and Tomas D: Immunohistochemical expression and prognostic
significance of HIF-1α and VEGF-C in neuroendocrine breast cancer.
Anticancer Res. 32:5227–5232. 2012.PubMed/NCBI
|
|
12
|
Kaelin WG Jr: How oxygen makes its
presence felt. Genes Dev. 16:1441–1445. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Nekrutenko A, Hillis DM, Patton JC,
Bradley RD and Baker RJ: Cytosolic isocitrate dehydrogenase in
humans, mice, and voles and phylogenetic analysis of the enzyme
family. Mol Biol Evol. 15:1674–1684. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Boisselier B, Gállego Pérez-Larraya J,
Rossetto M, Labussière M, Ciccarino P, Marie Y, Delattre JY and
Sanson M: Detection of IDH1 mutation in the plasma of patients with
glioma. Neurology. 79:1693–1698. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Shechter I, Dai P, Huo L and Guan G: IDH1
gene transcription is sterol regulated and activated by SREBP-1a
and SREBP-2 in human hepatoma HepG2 cells: Evidence that IDH1 may
regulate lipogenesis in hepatic cells. J Lipid Res. 44:2169–2180.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Memon AA, Chang JW, Oh BR and Yoo YJ:
Identification of differentially expressed proteins during human
urinary bladder cancer progression. Cancer Detect Prev. 29:249–255.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zhao S, Lin Y, Xu W, Jiang W, Zha Z, Wang
P, Yu W, Li Z, Gong L, Peng Y, et al: Glioma-derived mutations in
IDH1 dominantly inhibit IDH1 catalytic activity and induce
HIF-1alpha. Science. 324:261–265. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Hu X, Liu Y, Qin C, Pan Z, Luo J, Yu A and
Cheng Z: Up-regulated isocitrate dehydrogenase 1 suppresses
proliferation, migration and invasion in osteosarcoma: In vitro and
in vivo. Cancer Lett. 346:114–121. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Lv F, Du R, Shang W, Suo S, Yu D and Zhang
J: HIF-1α silencing inhibits the growth of osteosarcoma cells by
inducing apoptosis. Ann Clin Lab Sci. 46:140–146. 2016.PubMed/NCBI
|
|
20
|
Roncuzzi L, Pancotti F and Baldini N:
Involvement of HIF-1α activation in the doxorubicin resistance of
human osteosarcoma cells. Oncol Rep. 32:389–394. 2014.PubMed/NCBI
|
|
21
|
Zhang B, Guo W, Yu L, Wang F, Xu Y, Liu Y
and Huang C: Cobalt chloride inhibits tumor formation in
osteosarcoma cells through upregulation of HIF-1α. Oncol Lett.
5:911–916. 2013.PubMed/NCBI
|
|
22
|
Hu X, Yu AX, Qi BW, Fu T, Wu G, Zhou M,
Luo J and Xu JH: The expression and significance of IDH1 and p53 in
osteosarcoma. J Exp Clin Cancer Res. 29:432010. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Usnarska-Zubkiewicz L, Mazur G, Wróbel T,
Poreba M and Kuliczkowski K: Expression of serum vascular
endothelial growth factor correlates with clinical outcome in
multiple myeloma. Pol Arch Med Wewn. 110:719–724. 2003.(In Polish).
PubMed/NCBI
|
|
24
|
Wu L, Peng CW, Hou JX, Zhang YH, Chen C,
Chen LD and Li Y: Coronin-1C is a novel biomarker for
hepatocellular carcinoma invasive progression identified by
proteomics analysis and clinical validation. J Exp Clin Cancer Res.
29:172010. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Podar K, Tai YT, Davies FE, Lentzsch S,
Sattler M, Hideshima T, Lin BK, Gupta D, Shima Y, Chauhan D, et al:
Vascular endothelial growth factor triggers signaling cascades
mediating multiple myeloma cell growth and migration. Blood.
98:428–435. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Oda S, Oda T, Nishi K, Takabuchi S,
Wakamatsu T, Tanaka T, Adachi T, Fukuda K, Semenza GL and Hirota K:
Macrophage migration inhibitory factor activates hypoxia-inducible
factor in a p53-dependent manner. PLoS One. 3:e22152008. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Neal CS, Michael MZ, Rawlings LH, Van der
Hoek MB and Gleadle JM: The VHL-dependent regulation of microRNAs
in renal cancer. BMC Med. 8:642010. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Amary MF, Bacsi K, Maggiani F, Damato S,
Halai D, Berisha F, Pollock R, ODonnell P, Grigoriadis A, Diss T,
et al: IDH1IDH2 mutations are frequent events in central
chondrosarcoma and central and periosteal chondromas but not in
other mesenchymal tumours. J Pathol. 224:334–343. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
MacKenzie ED, Selak MA, Tennant DA, Payne
LJ, Crosby S, Frederiksen CM, Watson DG and Gottlieb E:
Cell-permeating alpha-ketoglutarate derivatives alleviate
pseudohypoxia in succinate dehydrogenase-deficient cells. Mol Cell
Biol. 27:3282–3289. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Ingebretsen OC: Mechanism of the
inhibitory effect of glyoxylate plus oxaloacetate and oxalomalate
on the NADP-specific isocitrate dehydrogenase. Biochim Biophys
Acta. 452:302–309. 1976. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Krell D, Mulholland P, Frampton AE, Krell
J, Stebbing J and Bardella C: IDH mutations in tumorigenesis and
their potential role as novel therapeutic targets. Future Oncol.
9:1923–1935. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Yang X, Du T, Wang X, Zhang Y, Hu W, Du X,
Miao L and Han C: IDH1, a CHOP and C/EBPβ-responsive gene under ER
stress, sensitizes human melanoma cells to hypoxia-induced
apoptosis. Cancer Lett. 365:201–210. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Semenza GL: Expression of
hypoxia-inducible factor 1: Mechanisms and consequences. Biochem
Pharmacol. 59:47–53. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Metallo CM, Gameiro PA, Bell EL, Mattaini
KR, Yang J, Hiller K, Jewell CM, Johnson ZR, Irvine DJ, Guarente L,
et al: Reductive glutamine metabolism by IDH1 mediates lipogenesis
under hypoxia. Nature. 481:380–384. 2011.PubMed/NCBI
|
|
35
|
Jang BC: The fruit juice of Morinda
citrifolia (noni) downregulates HIF-1α protein expression through
inhibition of PKB, ERK-1/2, JNK-1 and S6 in manganese-stimulated
A549 human lung cancer cells. Int J Mol Med. 29:499–504.
2012.PubMed/NCBI
|
|
36
|
Qian J, Bai H, Gao Z, Dong YU, Pei J, Ma M
and Han B: Downregulation of HIF-1α inhibits the proliferation and
invasion of non-small cell lung cancer NCI-H157 cells. Oncol Lett.
11:1738–1744. 2016.PubMed/NCBI
|
|
37
|
Akakura N, Kobayashi M, Horiuchi I, Suzuki
A, Wang J, Chen J, Niizeki H, Kawamura Ki, Hosokawa M and Asaka M:
Constitutive expression of hypoxia-inducible factor-1alpha renders
pancreatic cancer cells resistant to apoptosis induced by hypoxia
and nutrient deprivation. Cancer Res. 61:6548–6554. 2001.PubMed/NCBI
|
|
38
|
Krishnamachary B, Berg-Dixon S, Kelly B,
Agani F, Feldser D, Ferreira G, Iyer N, LaRusch J, Pak B, Taghavi
P, et al: Regulation of colon carcinoma cell invasion by
hypoxia-inducible factor 1. Cancer Res. 63:1138–1143.
2003.PubMed/NCBI
|
